Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Current Opinion in Neurology
|
September 13, 2005
New developments in diabetic neuropathy
Kelli A Sullivan, Eva L Feldman
Endocrinology
|
August 23, 2008
Insulin-like growth factors in the peripheral nervous system
Kelli A Sullivan, Bhumsoo Kim, Eva L Feldman
Antioxidants & Redox Signaling
|
January 4, 2011
Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes
Bhumsoo Kim, Kelli A Sullivan, Carey Backus, et al.
Journal of Integrative Neuroscience
|
March 11, 2004
Applying database technology to clinical and basic research bioinformatics projects
Thomas P Nadeau, Kelli A Sullivan, Toby J Teorey, et al.
Current Drug Targets
|
January 29, 2008
Criteria for creating and assessing mouse models of diabetic neuropathy
Kelli A Sullivan, Stephen I Lentz, John L Roberts, et al.
BMC Nephrology
|
March 17, 2006
Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment
Brian Siu, Jharna Saha, William E Smoyer, et al.
Diabetes Care
|
October 9, 2013
Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy
Junguk Hur, Kelli A Sullivan, Brian C Callaghan, et al.
Neuroscience Letters
|
August 10, 2010
The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice
Sang Su Oh, John M Hayes, Catrina Sims-Robinson, et al.
Endocrinology
|
June 28, 2008
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
Timothy D Wiggin, Matthias Kretzler, Subramaniam Pennathur, et al.
Diabetes
|
May 5, 2009
Elevated triglycerides correlate with progression of diabetic neuropathy
Timothy D Wiggin, Kelli A Sullivan, Rodica Pop-Busui, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Current Opinion in Neurology
|
September 13, 2005
New developments in diabetic neuropathy
Kelli A Sullivan, Eva L Feldman
Endocrinology
|
August 23, 2008
Insulin-like growth factors in the peripheral nervous system
Kelli A Sullivan, Bhumsoo Kim, Eva L Feldman
Antioxidants & Redox Signaling
|
January 4, 2011
Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes
Bhumsoo Kim, Kelli A Sullivan, Carey Backus, et al.
Journal of Integrative Neuroscience
|
March 11, 2004
Applying database technology to clinical and basic research bioinformatics projects
Thomas P Nadeau, Kelli A Sullivan, Toby J Teorey, et al.
Current Drug Targets
|
January 29, 2008
Criteria for creating and assessing mouse models of diabetic neuropathy
Kelli A Sullivan, Stephen I Lentz, John L Roberts, et al.
BMC Nephrology
|
March 17, 2006
Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment
Brian Siu, Jharna Saha, William E Smoyer, et al.
Diabetes Care
|
October 9, 2013
Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy
Junguk Hur, Kelli A Sullivan, Brian C Callaghan, et al.
Neuroscience Letters
|
August 10, 2010
The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice
Sang Su Oh, John M Hayes, Catrina Sims-Robinson, et al.
Endocrinology
|
June 28, 2008
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice
Timothy D Wiggin, Matthias Kretzler, Subramaniam Pennathur, et al.
Diabetes
|
May 5, 2009
Elevated triglycerides correlate with progression of diabetic neuropathy
Timothy D Wiggin, Kelli A Sullivan, Rodica Pop-Busui, et al.
Page
of 2